These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Contraception in female risk patients]. Wolf AS Med Welt; 1980 May; 31(18):654-6. PubMed ID: 7402070 [TBL] [Abstract][Full Text] [Related]
43. [Thromboembolic complications in the use of oral estrogen-gestagen contraceptives]. Smírová S; Chochola M; Varejka P; Aschermann M Vnitr Lek; 2001 Jul; 47(7):460-4. PubMed ID: 11505717 [TBL] [Abstract][Full Text] [Related]
44. Oestrogens and blood coagulation. von Kaulla KN Triangle; 1976; 15(1):9-17. PubMed ID: 785733 [No Abstract] [Full Text] [Related]
45. The haemostatic mechanism in oral contraception. Hilden M; Amris CJ; Starup J Acta Obstet Gynecol Scand; 1967; 46(4):562-71. PubMed ID: 6082549 [No Abstract] [Full Text] [Related]
46. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives. Gordon EM; Ratnoff OD; Jones PK J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063 [TBL] [Abstract][Full Text] [Related]
47. [Hormonal contraceptive therapy and thromboembolic disease]. Narvaiza MJ; Hernández M; Arrizabalaga B; Solana JM; Pérez Val JA; Rocha E Rev Med Univ Navarra; 1980 Dec; 24(4):49-53. PubMed ID: 7038816 [TBL] [Abstract][Full Text] [Related]
48. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA; Oza BP; Colomer R; Lupu R Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863 [TBL] [Abstract][Full Text] [Related]
52. Oral contraceptives and thromboembolism. IPPF Med Bull; 1967; 1(5):4. PubMed ID: 12304982 [TBL] [Abstract][Full Text] [Related]
53. Chlormadinone acetate and its effect on the hemostatic mechanism. Wodzicki AM; Coopland AT Can Med Assoc J; 1972 Jul; 107(1):38-41. PubMed ID: 4114470 [TBL] [Abstract][Full Text] [Related]
54. Thromboembolism and the pill -- new data. IPPF Med Bull; 1968; 2(4):2-3. PubMed ID: 12275471 [TBL] [Abstract][Full Text] [Related]
55. The pill: is low estrogen the answer? Peck RL Curr Prescr; 1976 Sep; 2(9):19. PubMed ID: 12229573 [TBL] [Abstract][Full Text] [Related]
56. Cyclical changes in coagulation factors associated with the use of progestational agents. McGrath KM; Castaldi PA Haemostasis; 1975; 4(2):73-80. PubMed ID: 1205338 [TBL] [Abstract][Full Text] [Related]
57. [Combined contraceptives and cardiovascular risk]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199 [TBL] [Abstract][Full Text] [Related]
58. [Oral contraceptives and thromboembolism (author's transl)]. Sato K; Ogino M; Nakabayashi M; Sakamoto S Kokyu To Junkan; 1978 Mar; 26(3):212-20. PubMed ID: 349637 [No Abstract] [Full Text] [Related]
59. The effect of oral contraceptives on factor VIII levels. Crowell EB; Clatanoff DV; Kiekhofer W J Lab Clin Med; 1971 Apr; 77(4):551-7. PubMed ID: 5554340 [No Abstract] [Full Text] [Related]
60. Oral contraceptives: their side effects and ophthalmological manifestations. Chizek DJ; Franceschetti AT Surv Ophthalmol; 1969 Sep; 14(2):90-105. PubMed ID: 4900372 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]